Concepedia

Amir Avan

AA

Statistics

Publications

15

Citations

939

H-Index

15

Active since

2012

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

University of Pisa

Mashhad University of Medical Sciences

Fondazione Pisa

Massachusetts General Hospital

Amir Avan is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, oncology, and molecular oncology.

Publications per year

2012–2020

15

Publications

15

Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells

Amir Avan, Francesco Crea, Elisa Paolicchi et al. · Molecular Cancer Therapeutics · 2012 · 98 citations · Full text

, , +17

Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing

Maria Rovithi, Amir Avan, Niccola Funel et al. · Scientific Reports · 2017 · 90 citations · Full text

, , +17

Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met–driven Pancreatic Carcinoma

Amir Avan, Viola Caretti, Niccola Funel et al. · Cancer Research · 2013 · 89 citations · Full text

, , +17

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer

Daniela Massihnia, Amir Avan, Niccola Funel et al. · Journal of Hematology & Oncology · 2017 · 84 citations · Full text

, , +17

Role of CYB5A in Pancreatic Cancer Prognosis and Autophagy Modulation

Elisa Giovannetti, Qiuyan Wang, Amir Avan et al. · JNCI Journal of the National Cancer Institute · 2013 · 83 citations · Full text

, , +17

1–5 of 15